Results 1 to 10 of about 10,756,993 (383)
Mast Cells: A New Frontier for Cancer Immunotherapy
Cells, 2021 Mast cells are unique tissue-resident immune cells of the myeloid lineage that have long been implicated in the pathogenesis of allergic and autoimmune disorders. More recently, mast cells have been recognized as key orchestrators of anti-tumor immunity,
Jake N. Lichterman, Sangeetha M. Reddy
doaj +2 more sources
Cells, 2022 Mast cells (MCs) function as a component of the tumor microenvironment (TME) and have both pro- and anti-tumorigenic roles depending on the tumor type and its developmental stage. Several reports indicate the involvement of MCs in angiogenesis in the TME
Irit Shefler +3 more
doaj +1 more source
Frontiers in Immunology, 2023 The HMC-1.2 human mast cell (huMC) line is often employed in the study of attributes of neoplastic huMCs as found in patients with mastocytosis and their sensitivity to interventional drugs in vitro and in vivo.
Geethani Bandara +7 more
doaj +1 more source
Cells, 2021 Thymic stromal lymphopoietin (TSLP) is released by epithelial cells following disturbed homeostasis to act as “alarmin” and driver of Th2-immunity. Aberrant TSLP expression is a hallmark of atopic diseases, including atopic dermatitis (AD).
Magda Babina +3 more
doaj +1 more source
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Allergy. European Journal of Allergy and Clinical Immunology, 2020 Mast cells are (in)famous for their role in allergic diseases, but the physiological and pathophysiological roles of this ingenious cell are still not fully understood.
Joakim S. Dahlin +5 more
semanticscholar +1 more source
Oncogenic D816V-KIT signaling in mast cells causes persistent IL-6 production
Haematologica, 2020 Persistent dysregulation of IL-6 production and signaling have been implicated in the pathology of various cancers. In systemic mastocytosis, increased serum levels of IL-6 associate with disease severity and progression, although the mechanisms involved
Araceli Tobío +9 more
doaj +1 more source
Nature Communications, 2021 Osteoporosis and bone disease are common in patients with systemic mastocytosis. Here, the authors show that extracellular vesicles released by neoplastic mast cells of the patients block osteoblast differentiation and bone mineralization when injected ...
Do-Kyun Kim +9 more
doaj +1 more source
Butyrate inhibits human mast cell activation via epigenetic regulation of FcεRI‐mediated signaling
Allergy. European Journal of Allergy and Clinical Immunology, 2020 Short‐chain fatty acids (SCFAs) are fermented dietary components that regulate immune responses, promote colonic health, and suppress mast cell–mediated diseases.
Jelle Folkerts +12 more
semanticscholar +1 more source
Current Gastroenterology Reports, 2010 Mast cells have been considered for many years to participate specifically in allergic reactions through the release of cytokines, chemokines, proteases, leukotrienes, and bioactive polyamines. Emerging roles for mast cells have been identified recently, which highlight their relevance in both innate and adaptive immunity.
Terez Shea-Donohue +3 more
openaire +3 more sources
Journal of Innate Immunity, 2021 Mast cells were described and named by Paul Ehrlich in 1879. The observation was based on their unique dye-staining properties. The key roles of mast cells in allergic reactions through IgE-dependent release of histamine are well established [1]. However, mast cells also have a characteristic content of proteases, to which important roles in emerging ...
Arne Egesten, Heiko Herwald
openaire +4 more sources